Hematology/Oncology Physician — Blood Cancer & Trials

UPMC Central PA; Ross Township (Allegheny County); On-site; USD 350,000 - 550,000; Full time

Benefits offered by this job

Competitive salary

Professional development

Collaborative environment

State-of-the-art facilities

Job summary

Hillman Cancer Center, UPMC in York, PA, seeks a Hematologist/Oncologist to diagnose and treat malignant hematologic disorders, including leukemia, lymphoma, and myeloma, and participate in an adoptive immunotherapy program with Bispecific T cell Engagers.

The role involves inpatient and outpatient care and collaboration with a multidisciplinary team, with opportunities to participate in clinical trials and advance the center's leukemia program.

Qualifications

• MD or DO degree from an accredited medical school.
• Board certification/eligibility in Hematology and/or Oncology.
• Valid medical license to practice in PA or eligible for licensing.
• Strong clinical and research background in malignant hematology.
• Excellent communication and interpersonal skills.
• Commitment to patient-centered care.

Responsibilities

• Diagnose and treat patients with malignant hematologic disorders.
• Develop and implement individualized treatment plans.
• Participate in clinical research and trials.
• Collaborate with a multidisciplinary team of healthcare professionals.
• Provide education and support to patients and their families.
• Stay updated with the latest advancements in hematology and oncology.

Skills

MD/DO

Board certification/eligibility in Hem

Education

MD/DO degree

Board certification/eligibility in Hematology/Oncology

Job description

Hillman Cancer Center, UPMC in York, PA, seeks a Hematologist/Oncologist to diagnose and treat malignant hematologic disorders, including leukemia, lymphoma, and myeloma, and participate in an adoptive immunotherapy program with Bispecific T cell Engagers.

The role involves inpatient and outpatient care and collaboration with a multidisciplinary team, with opportunities to participate in clinical trials and advance the center's leukemia program.